Women bear a disproportionate burden of Alzheimer’s disease at every level: they develop it more often, decline faster after diagnosis, and provide the majority of care for others who have it. Of the 7.4 million Americans age 65 and older living with Alzheimer’s, roughly 4.4 million are women. That two-to-one split isn’t fully explained by the fact that women live longer. Biology, genetics, and even the way we test for the disease all play a role.
Why Women Develop Alzheimer’s More Often
The simplest explanation is longevity. Women live longer than men on average, and age is the strongest risk factor for Alzheimer’s. More years alive means more years in which the disease can take hold. But longevity alone doesn’t account for the gap.
One biological factor involves a protein called tau, which forms toxic tangles inside brain cells and is one of the hallmarks of Alzheimer’s. Women accumulate higher levels of tau tangles over their lifetimes than men do. NIH-funded research has identified a specific enzyme, encoded by a gene on the X chromosome, that appears to drive this difference. Women carry two copies of the X chromosome, and while one copy is usually silenced in each cell, the gene for this enzyme can remain active on both copies. The result: women’s brains may produce more of the enzyme, leading to more tau buildup. In brain tissue samples, higher levels of this enzyme were more strongly linked to tau tangles in female brains than in male brains.
Immune system differences may also contribute. Women generally have more robust immune responses than men, which is protective against infections but can fuel chronic inflammation in the brain over decades. That kind of low-grade neuroinflammation is increasingly recognized as a contributor to Alzheimer’s pathology.
A Common Gene Hits Women Harder
The APOE-e4 gene variant is the strongest known genetic risk factor for late-onset Alzheimer’s. About one in four people carries at least one copy. But the risk it confers is not equal between sexes.
Research tracking people with mild cognitive impairment (the stage that often precedes Alzheimer’s) found that women who carry APOE-e4 experienced faster cognitive decline than men with the same gene variant. The acceleration was striking: on a standard cognitive assessment scale, the rate of additional worsening in women was roughly double that of men. On a clinical dementia rating scale, it was nearly two and a half times greater. The variability in decline was also wider in women, meaning some women with this gene deteriorated much more rapidly than average.
Faster Decline After Diagnosis
The sex difference doesn’t stop at who gets the disease. Once cognitive impairment begins, women tend to lose ground more quickly. A study following nearly 400 people with mild cognitive impairment over up to eight years found that women progressed at significantly faster rates than men on both cognitive and functional measures. This wasn’t a subtle difference. The pattern held across multiple follow-up visits and was especially pronounced in women who also carried the APOE-e4 gene.
This faster trajectory has real consequences for planning. It means the window between an early diagnosis and the need for full-time care may be shorter for women, making early detection all the more important.
Why Early Signs Get Missed in Women
Here’s the cruel irony: one of women’s cognitive strengths may actually work against them when it comes to catching Alzheimer’s early. Throughout life, women consistently outperform men on verbal memory tests, the kind that ask you to recall a list of words or retell a short story. This advantage appears to function as a form of cognitive reserve, allowing women to compensate for underlying brain damage longer than men can.
The problem is that the memory tests used to screen for early Alzheimer’s typically use a single cutoff score for everyone, regardless of sex. A woman whose verbal memory has declined significantly from her personal baseline may still score above the diagnostic threshold simply because she started from a higher point. She looks “normal” on paper while disease is already well underway in her brain. By the time her scores finally dip low enough to trigger a diagnosis, the disease is often more advanced than it would be in a man diagnosed at the same score.
Researchers have called for sex-adjusted scoring on verbal memory tests to close this gap. Without that adjustment, women are essentially penalized for their own cognitive strengths, getting diagnosed later and missing the window when interventions could do the most good.
The Caregiving Burden
Women are overrepresented on both sides of Alzheimer’s. They make up the majority of patients, and they also make up 58% of dementia caregivers. That dual exposure compounds the toll.
Dementia caregiving is physically and emotionally demanding in ways that differ from other kinds of caregiving. It often involves managing behavioral symptoms, providing round-the-clock supervision, and navigating a slow, years-long decline in a loved one’s personality and independence. The health consequences for caregivers are well documented: nearly one in five reports fair or poor health, and close to two in five have at least two chronic diseases of their own. Caregivers frequently neglect their own medical needs, skip appointments, and delay treatment for their own conditions.
Because women are more likely to be the primary caregiver for a spouse or parent with Alzheimer’s, they face a compounding risk. Years of chronic stress, sleep disruption, and deferred self-care may themselves increase vulnerability to cognitive decline later on, though the precise degree of that risk is still being studied.
What This Means in Practice
If you’re a woman concerned about Alzheimer’s risk, a few things are worth knowing. First, subtle changes in memory or word-finding that seem minor to your doctor may be more significant than standard screening suggests. If you feel your memory has changed meaningfully from where it used to be, push for more thorough evaluation rather than accepting a normal screening score at face value. Neuropsychological testing that accounts for your educational background and baseline abilities can be more revealing than a quick office screen.
Second, the modifiable risk factors for Alzheimer’s (cardiovascular health, physical activity, sleep quality, social engagement, and management of conditions like diabetes and hypertension) are the same for both sexes, but they may matter even more for women given the compounding biological risks. Cardiovascular disease in midlife is a particularly strong predictor of later dementia, and women’s heart risks are often underrecognized in their own right.
Third, if you’re a caregiver, your own cognitive and physical health is not a secondary concern. The chronic stress of dementia caregiving is a legitimate health risk, not just an emotional hardship. Respite care, support groups, and regular medical checkups aren’t luxuries. They’re part of staying healthy enough to provide care without sacrificing your own future.